The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

1996 • 1,203 citations

Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart

1996 • 993 citations

Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α

1997 • 830 citations

Pathophysiologically Relevant Concentrations of Tumor Necrosis Factor-α Promote Progressive Left Ventricular Dysfunction and Remodeling in Rats

1998 • 810 citations

Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α

1998 • 602 citations

Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration.

1995 • 436 citations

Elevated soluble CD14 receptors and altered cytokines in chronic heart failure

1997 • 393 citations

Basic Mechanisms in Congestive Heart Failure

1994 • 365 citations

Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.

1991 • 348 citations

Hemodynamic Regulation of Tumor Necrosis Factor-α Gene and Protein Expression in Adult Feline Myocardium

1997 • 284 citations

Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation.

1993 • 242 citations

Cytokines and Cardiac Contractile Function

1997 • 209 citations

Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation

1998 • 200 citations

Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure.

1994 • 156 citations

Adenosine Inhibits Lipopolysaccharide-Induced Cardiac Expression of Tumor Necrosis Factor-α

1998 • 114 citations

Membrane current changes responsible for the positive inotropic effect of OPC-8212, a new positive inotropic agent, in single ventricular cells of the guinea pig heart.

1987 • 89 citations

Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor-α in vitro and in vivo

1997 • 88 citations

The Clinical Relevance of Circulating Tumor Necrosis Factor-α in Acute Decompensated Chronic Heart Failure Without Cachexia

1996 • 77 citations

Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia

1997 • 69 citations

Protection from T cell-mediated murine liver failure by phosphodiesterase inhibitors.

1997 • 67 citations

Differential Modulation of Cytokine Production by Drugs: Implications for Therapy in Heart Failure

1996 • 56 citations

Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.

1998 • 53 citations

Tumour necrosis factor is expressed in cardiac tissues of patients with heart failure

1996 • 52 citations

Pharmacological modulation of myocardial tumor necrosis factor alpha production by phosphodiesterase inhibitors.

1996 • 45 citations

ACE Inhibition

1997 • 23 citations

Immunomodulation: A new horizon for medicaltreatment of heart failure

1996 • 19 citations

Cited By (0)

Loading...